Sales decline 40.68% to Rs 9.83 crore
Net profit of Concord Drugs rose 475.00% to Rs 0.46 crore in the quarter ended September 2021 as against Rs 0.08 crore during the previous quarter ended September 2020. Sales declined 40.68% to Rs 9.83 crore in the quarter ended September 2021 as against Rs 16.57 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales9.8316.57 -41 OPM %16.795.37 -PBDT1.370.44 211 PBT0.800.11 627 NP0.460.08 475Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
